EDDP perchlorate
Based on 1 Customer Validation
EDDP perchlorate is a potent noncompetitive antagonist of neuronal nicotinic acetylcholine receptors (nAChRs). EDDP perchlorate is the major primary N-demethylated metabolite of the parent opioid. EDDP perchlorate inhibits nicotine-stimulated ion efflux by noncompetitively blocking the ion channel function of nAChR, but does not activate the traditional Opioid Receptor (Ki = 918 nM) signaling pathway. EDDP perchlorate is used in research on neurological diseases.
For research use only. We do not sell to patients.
- Purity : 98.93%
- CAS No.: 31161-17-8
- Formula: C20H24ClNO4
- Molecular Weight:377.86
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
EDDP (10 mg/kg; s.c.; single administration; administered 30 minutes before testing; 5-minute test) perchlorate shows no significant anxiolytic effect in the elevated plus maze anxiety model in adult male Sprague-Dawley rats[5].
EDDP (10 mg/kg; s.c.; administered immediately after the initial forced swim and at 20 h and 23 h before the test, for a total of 3 doses; 5-min test) perchlorate shows no significant antidepressant-like effect in the Sprague-Dawley rat forced swim depression model[5].
EDDP (1-10 mg/kg; i.p.; single administration; administered 10 minutes before the test; 6-minute test) perchlorate shows no significant antidepressant-like effect in the forced swim depression model in 129SvEv; C57BL/6J F1 hybrid mice[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 225-300 g at study start)[5]
-
Dosage:10 mg/kg
-
Administration:s.c.; single dose; 30 min before testing
-
Result:Rats spent a mean of 80 s in the open arms.
Vehicle-treated controls spent a mean of 104 s.
Percent open-arm entries did not differ among groups.
-
Animal Model:Sprague-Dawley (male, 225-300 g at study start)[5]
-
Dosage:10 mg/kg
-
Administration:s.c.; at 0, 20, and 23 h after pre-exposure
-
Result:At 10 mg/kg, did not reduce immobility time in the 300-s forced swim test.
-
Animal Model:129SvEv; C57Bl/6J F1 hybrid (male, 7-10 weeks, 25-35 g)[5]
-
Dosage:5 mg/kg and 10 mg/kg
-
Administration:i.p.; single dose; 10 min before testing
-
Result:Vehicle-treated control mice buried a mean of 11 marbles.
Reduced the number of marbles buried at 5 mg/kg.
At 10 mg/kg, no reduction in buried marbles was detected.
-
Animal Model:129SvEv; C57Bl/6J F1 hybrid (male, 7-10 weeks, 25-35 g)[5]
-
Dosage:1 mg/kg, 5 mg/kg, and 10 mg/kg
-
Administration:i.p.; single dose; 10 min before testing
-
Result:Vehicle-treated control mice spent a mean of 270 s immobile during the 6-min forced swim test.
At 1, 5, or 10 mg/kg, did not alter time spent immobile.
Chemical Information
-
CAS No. 31161-17-8
-
Appearance Solid
-
Molecular Weight 377.86
-
Formula C20H24ClNO4
-
Color White to off-white
-
SMILES
O=Cl(=O)([O-])=O.C[N+](C(C1)C)=C(CC)C1(C2=CC=CC=C2)C3=CC=CC=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Korean - KR (480 KB)
- Portuguese - PT (480 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)